| Department of Medicine

DOM In the News

Read about how the Department of Medicine is responding to the outbreak of the coronavirus respiratory illness COVID-19. See related COVID-19 publications.

Microbubble-Facilitated Ultrasound Catheter Ablation Causes Microvascular Damage and Fibrosis.

Streptococcus pneumoniae transmission in chronic-care facilities: description of an outbreak and review of management strategies.

Use of Electronic Health Records to Characterize Patients with Uncontrolled Hypertension in Two Large Health System Networks.

Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer: A Multisite Randomized Clinical Trial.

Lukejohn Day was named Chief Medical Officer at ZSFG

Lukejohn Day was named Chief Medical Officer at ZSFG. See the full announcement from Susan Ehrlich, ZSFG Chief Executive Officer here.

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.

Chitins and Chitinase Activity in Airway Diseases.

Goblet cell and mucin gene abnormalities in asthma.

Priming with endotoxin increases acute lung injury in mice by enhancing the severity of lung endothelial injury.

Expectations and Concerns of Older Adults With Cognitive Impairment About Their Relationship With Medical Providers: A Call for Therapeutic Alliances.

LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV.

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.

Confounding in genetic association studies and its solutions.

Signal and noise: applying a laboratory trigger tool to identify adverse drug events among primary care patients.

Association of lipoprotein-associated phospholipase A2 and risk of incident atrial fibrillation: Findings from 3 cohorts.